Filing by Certain Investment Companies of Rule 482 Advertising in Accordance With Rule 497 and the Note to Rule 482(e) (497ad)
November 08 2022 - 5:04AM
Edgar (US Regulatory)
Filed pursuant to Rule 497(a)
Registration No. 333-256733
Rule 482a
Ares Capital Corporation
8,000,000 Shares of Common Stock
Issuer: |
|
Ares Capital Corporation |
|
|
|
Symbol / Listing: |
|
ARCC / NASDAQ |
|
|
|
Base shares offered: |
|
8,000,000 shares (100% primary) |
|
|
|
Option to purchase additional shares: |
|
1,200,000 shares (100% primary) |
|
|
|
Price per share to the public: |
|
$18.95 |
|
|
|
Trade date: |
|
November 7, 2022 |
|
|
|
Closing date: |
|
November 10, 2022 |
|
|
|
CUSIP No.: |
|
04010L103 |
|
|
|
Joint Lead Book-Running Managers: |
|
Morgan Stanley & Co. LLC
BofA Securities, Inc.
UBS Securities LLC
RBC Capital Markets, LLC
Wells Fargo Securities, LLC |
|
|
|
Joint Book-Running Managers: |
|
Keefe, Bruyette & Woods, Inc.
Raymond James & Associates, Inc. |
|
|
|
Co-Managers |
|
Goldman Sachs & Co. LLC
Janney Montgomery Scott LLC
J.P. Morgan Securities LLC
Oppenheimer & Co. Inc.
Academy Securities, Inc.
Compass Point Research & Trading, LLC
Loop Capital Markets LLC
Samuel A. Ramirez & Company, Inc.
R. Seelaus & Co., LLC
Siebert Williams Shank & Co., LLC |
Investors are advised to carefully consider the investment objective,
risks, charges and expenses of Ares Capital before investing. The preliminary prospectus supplement dated November 7, 2022, together
with an accompanying prospectus dated June 3, 2021, which have been filed with the Securities and Exchange Commission, contain this
and other information about Ares Capital and should be read carefully before investing.
The information in the preliminary prospectus supplement and the
accompanying prospectus, and in this announcement, is not complete and may be changed. The preliminary prospectus supplement, the accompanying
prospectus and this announcement are not offers to sell any securities of Ares Capital and are not soliciting an offer to buy such securities
in any jurisdiction where such offer and sale is not permitted.
A shelf registration statement relating to these securities is on
file with and has been declared effective by the Securities and Exchange Commission. The offering may be made only by means of a preliminary
prospectus supplement and an accompanying prospectus.
Copies of the preliminary prospectus supplement (and accompanying
prospectus) may be obtained from Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus
Department; BofA Securities, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department,
or email dg.prospectus_requests@bofa.com; UBS Securities LLC at 1285 Avenue of the Americas, New York, New York, 10019, Attn: Prospectus
Department, by telephone at (888) 827-7275, or by email: ol-prospectusrequest@ubs.com; RBC Capital Markets, LLC at 200 Vesey Street, 8th
Floor, New York, New York, 10281, Attn: Prospectus Department, or by telephone at (877) 822-4089; or Wells Fargo Securities at 500 West
33rd Street, New York, New York, 10001, Attn: Equity Syndicate Department, by calling toll free 1-800-326-5897, or by e-mail at cmclientsupport@wellsfargo.com.
ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR AFTER THIS
MESSAGE ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED
AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.
Ares Capital (NASDAQ:ARCC)
Historical Stock Chart
From Apr 2024 to May 2024
Ares Capital (NASDAQ:ARCC)
Historical Stock Chart
From May 2023 to May 2024